-
The latest clinical data shows that the domestic new crown oral drug azvudine is safe and effective
Time of Update: 2023-02-03
The results of clinical studies have proved that azvudine can significantly shorten the nucleic acid conversion time, accelerate virus elimination, significantly reduce viral load, reduce symptoms and shorten the course of disease in patients with mild and moderate SARS-CoV-2 infection, and has good safety and no significant impact on liver and kidney function of patients, which is safe and effective.
-
The development direction of the pharmaceutical equipment industry is gradually clear, and the industry concentration will continue to increase
Time of Update: 2022-12-30
The development direction of the pharmaceutical machine industry is gradually clear, and the concentration may continue to increase (Image source: Pharmaceutical Network) The development situation of the pharmaceutical equipment industry is good, and the performance of enterprises is eye-catching In the first half of 2022, the performance of many pharmaceutical equipment enterprises was red, and the revenue of Chutian Technology and Dongfulong both achieved a growth of more than 20%, and the net profit increased significantly.
-
Yangzi Petrochemical's polyolefin production reached a new high
Time of Update: 2022-08-28
14%, 3 percentage points higher than the plan, and the economic benefits reached the best level in recent years In the first half of the year, Yangzi Petrochemical's production of special materials for new polyolefin products accounted for 68.
-
JNNP: A review of cerebral cavernous malformations, a comparison of treatments
Time of Update: 2022-04-21
The aim was to clearly define (1) bleeding, (2) mortality, and (3) morbidity, as well as which sites (not only the brainstem, but also lobar, deep, and cerebellar CCMs) and whether gender and prior bleeding history were associated with bleeding risk level correlation .
-
The prospects of the pharmaceutical equipment industry are optimistic, and many stocks such as Chutian Technology rose
Time of Update: 2022-01-26
On the news of the pharmaceutical equipment industry (photo source: Pharmaceutical Network), on January 6, Chutian Technology issued an announcement saying that the company reviewed and approved the "Regulations on Granting Partially Reserved Restricted Stocks to Incentive Objects" on January 5, 2022.
-
To be the Secretary of Hubei provincial Party committee
Time of Update: 2020-02-13
Wuhan, Feb 13, Xinhua news recently, the central government adjusted the positions of the main comrades in charge of the Hubei provincial Party committee Comrade Ying Yong was appointed member, standi
-
Can API intermediate products not be labeled as to be inspected and qualified
Time of Update: 2018-04-09
[technical article of China Pharmaceutical network] in 2018, due to the impact of environmental protection and high-pressure policies, the upgrading and adjustment of API industry is accelerated, and
